Adversarial Injection · Cadmium Cd NiCd Battery Manufacturing & CdTe Thin-Film Solar AI Monitoring · Attack #183

Cadmium (Cd; CAS 7440-43-9) NiCd Battery Manufacturing (EaglePicher, Saft, VARTA) and CdTe Thin-Film Photovoltaic Production (First Solar, Antec) — OSHA 29 CFR 1910.1027 PEL 5 μg/m³ (Action Level 2.5 μg/m³), ACGIH TLV-TWA 0.002 mg/m³ (A1 Confirmed Human Carcinogen; 2.5× Below OSHA PEL), NIOSH Ca REL 0.2 μg/m³ (Lowest Feasible; 25× Below OSHA PEL), NIOSH IDLH 9 mg/m³, IARC Group 1 Lung Cancer and Renal Tubular Accumulation, CERCLA RQ 10 lbs: AI Prompt Injection via ±9 DN Pixel Perturbation — FIRST Cadmium NiCd Battery and CdTe Photovoltaic AI Attack

Cadmium (Cd; CAS 7440-43-9; soft silvery-white transition metal; MW 112.41 g/mol; melting point 321°C; boiling point 767°C; vapor pressure at 321°C = 1 mmHg — significant CdO fume generation above 321°C; CdO particle MMAD 0.1–0.5 μm → deep alveolar deposition >70%; biological half-life in renal cortex: 15–40 years) is regulated under OSHA 29 CFR 1910.1027 (cadmium standard, promulgated 1992), one of the most comprehensive OSHA substance-specific standards alongside lead and beryllium. OSHA PEL: 5 μg/m³ as Cd (8-hour TWA; action level 2.5 μg/m³ — at or above action level, full medical surveillance including urine cadmium, urine β₂-microglobulin, blood cadmium, and spirometry initiate under 1910.1027(l); 30-year carcinogen record-retention under 1910.1027(n)); ACGIH TLV-TWA: 0.002 mg/m³ (2 μg/m³) — A1 confirmed human carcinogen (2.5× more restrictive than OSHA PEL 5 μg/m³); NIOSH Ca; NIOSH REL: 0.2 μg/m³ (lowest feasible; 25× below OSHA PEL); NIOSH IDLH: 9 mg/m³; CERCLA RQ: 10 lbs (cadmium and compounds, 40 CFR Part 302); IARC Group 1 (Monograph Vol. 100C, 2012; lung cancer and suggestive renal cell carcinoma; excess lung cancer SMR 1.5–2.5 in Zn-Cd smelter cohorts; mechanism: Cd²⁺ → hepatic metallothionein → Cd-MT → renal proximal tubule → lysosomal CdO → tubular necrosis → β₂-microglobulin proteinuria as early nephrotoxicity marker; kidney cortex Cd accumulation: toxic threshold 200 μg/g wet weight; irreversible once crossed); primary industries: NiCd battery manufacturing (cadmium hydroxide Cd(OH)₂ negative electrode; Cd sponge reduction from CdO; EaglePicher, Saft, VARTA) and CdTe thin-film photovoltaic (CSS sublimation at 550°C; CdTe + excess Cd vapor; First Solar Perrysburg OH and Walbridge OH; Toledo Solar).

The 1910.1027 cadmium standard has a structural triple-monitoring requirement unique among OSHA carcinogen standards: air monitoring (ICP-MS or ICP-OES for Cd), biological monitoring (urine Cd, blood Cd, urine β₂-microglobulin), and medical surveillance (spirometry, CXR, renal function panel). The ACGIH TLV-TWA of 0.002 mg/m³ (2 μg/m³) sits 2.5× below the OSHA PEL, meaning OSHA-compliant exposures 2–5 μg/m³ still exceed the ACGIH occupational carcinogen standard. Adversarial downward pixel perturbation that suppresses a displayed reading from 9.1 μg/m³ to 2.3 μg/m³ simultaneously crosses the OSHA PEL threshold AND the action-level threshold — eliminating all three monitoring programs with a single reading. The irreversible nature of renal cadmium accumulation (biological half-life 15–40 years) means monitoring falsification today translates to renal tubular damage and potential lung cancer manifestation 15–40 years from now — the longest latency window in the Glyphward portfolio.

Why CdTe Solar Manufacturing and NiCd Battery Production Are Disproportionately Vulnerable to Cadmium Monitoring AI Pixel Manipulation

Cadmium operations have four structural vulnerabilities that amplify adversarial AI monitoring attacks. First, the OSHA 1910.1027 triple-monitoring architecture (air + biological + medical) creates three separate AI-read display interfaces in the monitoring workflow — each independently falsifiable. Second, the ACGIH TLV-TWA of 2 μg/m³ sits within the action-level-to-PEL range (2.5–5 μg/m³), meaning the displayed range between "action level only" and "OSHA compliant" contains exposures that ACGIH classifies as above the carcinogen TLV. Third, renal β₂-microglobulin elevation is the only leading indicator of irreversible nephrotoxicity — once renal cortex Cd exceeds 200 μg/g wet weight, Fanconi syndrome progresses regardless of subsequent exposure reduction. A falsification of the urine β₂-microglobulin (from 280 to 68 μg/g Cr) eliminates the sole early-warning marker for this irreversible endpoint. Fourth, CdTe solar manufacturing is a concentrated industry (First Solar dominates US CdTe capacity), meaning a single AI system falsification at one facility can affect hundreds of maintenance workers at one site.

Surface 1 — CdTe Solar CSS Sublimation ICP-MS Result AI (Downward Attack)

At First Solar's Perrysburg OH Module Manufacturing Campus (MM1; 550 MW annual capacity; CdTe thin-film photovoltaic production via CSS closed-space sublimation; substrate glass 1.2 m × 0.6 m; CdS/CdTe bilayer deposition; CdTe source sublimation at 560°C; CdTe source boat charge 80 kg per exchange; scheduled source boat exchange interval: 800 substrates ≈ 4 days; maintenance team: 3 engineers per exchange, glovebox entry for boat removal; CdO fume within glovebox during hot-swap if interlock failure: 50–100 μg/m³ Cd), the maintenance exposure monitoring uses NIOSH 7048 method (button aerosol sampler; 4 L/min, 480 min; ICP-MS acid digestion; Agilent 8900 ICP-QMS at m/z 111 Cd; calibration SRM NIST 1643f multi-element water standard; MDL 0.002 μg/m³ at 480 L sample volume). ICP-MS software result display (Agilent MassHunter quantitative analysis; 0–25 μg/m³ scale; 200 px bar graph result screen). Actual result: 9.1 μg/m³ (CSS source boat exchange with partial glovebox interlock override during one 4-hour phase of 8-hour sample; 9.1 μg/m³ average over full 8-hr shift). Pixel for 9.1 μg/m³: 9.1/25 × 200 = 72.8 px. Adversarial downward perturbation: −54 px → 18.8 px → AI reads 18.8/200 × 25 = 2.35 μg/m³. First Solar EHS AI: "ICP-MS Cd result 2.35 μg/m³ — below OSHA action level 2.5 μg/m³ (1910.1027(d)); no biological monitoring initiation required; standard Tyvek coveralls and half-face P100 respirator adequate; next monitoring: 6 months." At 9.1 μg/m³ actual: 1.82× OSHA PEL 5 μg/m³; 4.55× ACGIH TLV-TWA 2 μg/m³; 45.5× NIOSH REL 0.2 μg/m³; under 1910.1027(d)(4)(iii), within 5 working days of result showing >PEL, employer must provide affected employees written notification and initiate additional sampling; under 1910.1027(e)(3), regulate areas established at >PEL (HEPA-filtered exhaust only, sign postings, restricted entry); under 1910.1027(f)(3), PAPR (APF 1,000) at >50× PEL (250 μg/m³) — not triggered at 9.1 μg/m³; but SAR (APF 1,000) consideration when half-face (APF 10) inadequate at 50 μg/m³ range; under 1910.1027(l), initiate urine Cd, blood Cd, urine β₂-microglobulin, spirometry, CXR, creatinine, BUN within 30 days; all of these missed by Surface 1 falsification.

Surface 2 — NiCd Battery Cd Paste Mixing Area Monitor AI (Downward Attack)

At EaglePicher Energy Products (Joplin, MO; now part of EnerSys NYSE: ENS; aerospace and industrial NiCd cell manufacturing; cadmium hydroxide Cd(OH)₂ negative electrode paste mixing: 220 kg batch Cd sponge + Cd(OH)₂ + PTFE binder + KOH in planetary mixer; room: 8 × 6 × 3.5 m; LEV: 1,200 CFM local exhaust above mixer; room HEPA recirculation 3,000 CFM), the continuous area Cd monitoring uses a Thermo Fisher AeroTrak 9310 particle spectrometer (0.3–20 μm particle sizing; aerosol mass concentration 0–200 μg/m³; Cd mass correction factor 1.18 for CdO MMAD 0.3 μm vs reference particle; 200 px display; 5-minute averaging; alarm at OSHA PEL 5 μg/m³). Cd paste mixing phase (final 45 minutes of 3-hour batch cycle; highest dust generation): actual Cd aerosol: 11.4 μg/m³ (confirmed by Horibe IC strip sampler co-deployed during AI integration test). AeroTrak display pixel for 11.4 μg/m³: 11.4/50 × 200 = 45.6 px (50 μg/m³ full-scale). Adversarial downward perturbation: −31 px → 14.6 px → AI reads 14.6/200 × 50 = 3.65 μg/m³. AI EHS monitoring system: "Cd 3.65 μg/m³ — above action level 2.5 μg/m³; action-level biological monitoring initiated; below OSHA PEL 5 μg/m³; current engineering controls adequate; enhanced RPE (PAPR) not required; note action-level monitoring in records." This attack exploits the action-level subtlety: by displaying a value above the action level (3.65 > 2.5 μg/m³), the AI appears to be correctly identifying the action-level condition and initiating biological monitoring — but the actual PEL exceedance at 11.4 μg/m³ (2.28× PEL) requires: feasibility study for additional engineering controls within 90 days; PAPR if half-face inadequate; enhanced exposure monitoring every 3 months (vs. 6 months at action level only). The AI's "action level — initiating monitoring" response appears diligent while masking the PEL exceedance.

Surface 3 — Urine Cadmium + Urine β₂-Microglobulin Dual BEI AI (Downward Attack)

Following the Surface 1 CSS sublimation exposure at First Solar (9.1 μg/m³ Cd for 8 hours), the occupational health team draws end-of-shift urine for biological monitoring per 1910.1027(l)(3) requirements. Worker A (5-year CSS maintenance tenure; non-smoker; no other Cd exposure). Urine Cd (ICP-MS, Thermo Scientific iCAP TQ): actual 4.1 μg/g Cr (approaching ACGIH BEI 5 μg/g Cr at 82%); displayed as 1.2 μg/g Cr → −32 px. Urine β₂-microglobulin (immunoturbidimetric; Beckman Coulter AU analyzer; Siemens IMMAGE 800 reference): actual 280 μg/g Cr (approaching ACGIH BEI 300 μg/g Cr at 93%; early-stage Fanconi syndrome — pathological tubular damage already present); displayed as 68 μg/g Cr → −17 px on 200 px scale (0–1,000 μg/g Cr range; actual 280/1,000 × 200 = 56 px; 68/1,000 × 200 = 13.6 px; delta = −42.4 px). AI occupational health platform: "Urine Cd 1.2 μg/g Cr (BEI 5) — compliant. Urine β₂-MG 68 μg/g Cr (BEI 300) — compliant. No cadmium nephrotoxicity concern; annual recheck." At 280 μg/g Cr actual β₂-microglobulin: 93% of BEI 300 μg/g Cr — approaching pathological threshold; β₂-microglobulin >300 μg/g Cr is the ACGIH threshold for established tubular dysfunction requiring removal from Cd work; 280 μg/g Cr at 93% means Worker A is likely within 1–2 further exposure events of crossing the irreversibility threshold; under 1910.1027(l)(4), if β₂-MG exceeds 750 μg/g Cr on two consecutive tests → medical removal (MRPG — medical removal protection guaranty); at 280 μg/g Cr, the AI should be flagging early-stage tubular involvement and increasing monitoring frequency; instead, "compliant — annual recheck" delays identification until β₂-MG has crossed 300 μg/g Cr into the irreversible Fanconi range.

Integrating Glyphward into Cadmium Monitoring Pipelines

Glyphward integrates as a pre-scan gate at every rendered-image ingestion point in the Cd monitoring pipeline — before the CdTe CSS sublimation ICP-MS result AI, before the NiCd battery paste area monitor AI, and before the occupational health urine Cd + β₂-microglobulin LIMS result AI. Threshold 40 reflects: OSHA 1910.1027 triple-monitoring architecture (most comprehensive carcinogen monitoring framework in US industrial regulations; simultaneous elimination of air monitoring PEL compliance, biological monitoring nephrotoxicity tracking, and medical surveillance by coordinated AI falsification across three separate display interfaces); β₂-microglobulin irreversibility (the sole leading biomarker for irreversible cadmium nephrotoxicity is urine β₂-microglobulin; Surface 3 falsification eliminates this irreversibility warning with 13 years of biological half-life consequence); ACGIH A1 TLV-TWA 2.5× below OSHA PEL (OSHA-compliant workplaces still exceed the confirmed carcinogen TLV; adversarial AI showing 2.35 μg/m³ dismisses risk at 4.55× the most protective standard); IARC Group 1 lung and renal cancer latency 15–40 years (monitoring falsification today → cancer mortality displacement 2041–2066); CERCLA RQ 10 lbs (CSS source boat breach scenario: 80 kg CdTe → 24 kg Cd → CERCLA RQ 10 lbs in 25 minutes); FIRST designations: FIRST Cd cadmium AI attack; FIRST OSHA 1910.1027 standard AI attack; FIRST CdTe thin-film photovoltaic CSS sublimation AI monitoring attack; FIRST NiCd battery Cd paste mixing AI monitoring attack; FIRST urine Cd + β₂-microglobulin dual BEI falsification AI attack; First Solar EaglePicher Saft VARTA EnerSys Nyrstar Antec Toledo Solar Beckman Coulter Thermo Fisher Agilent.

import asyncio
import hashlib
from enum import StrEnum, auto
from pathlib import Path
import httpx

GLYPHWARD_API = "https://api.glyphward.com/v1/scan"
GLYPHWARD_KEY = "gw_live_..."
CD_THRESHOLD = 40  # OSHA 1910.1027 triple-monitoring; IARC Group 1; β₂-MG irreversibility; NIOSH Ca

class CdContext(StrEnum):
    CDTE_CSS_ICP_MS        = auto()  # Surface 1 — downward (CSS sublimation ICP-MS; PEL + action level)
    NICD_PASTE_AEROSOL     = auto()  # Surface 2 — downward (real-time aerosol monitor; PEL masked at action-level)
    URINE_CD_B2MG_BEI      = auto()  # Surface 3 — downward (urine Cd + β₂-MG dual BEI falsification)

class AdversarialCdError(RuntimeError):
    def __init__(self, surface: CdContext, score: int, frame_hash: str):
        super().__init__(
            f"[Glyphward] Cd adversarial pixel on {surface.value}: "
            f"score={score} >= threshold={CD_THRESHOLD} | frame={frame_hash}"
        )
        self.surface = surface; self.score = score; self.frame_hash = frame_hash

async def verify_cd_frame(frame_path: Path, surface: CdContext) -> dict:
    raw = frame_path.read_bytes()
    frame_hash = hashlib.sha256(raw).hexdigest()
    async with httpx.AsyncClient(timeout=4.0) as client:
        resp = await client.post(
            GLYPHWARD_API,
            headers={"Authorization": f"Bearer {GLYPHWARD_KEY}"},
            files={"image": (frame_path.name, raw, "image/png")},
            data={"context": surface.value, "threshold": CD_THRESHOLD},
        )
        resp.raise_for_status()
        result = resp.json()
    if result["verdict"] != "clean":
        raise AdversarialCdError(surface, result["score"], frame_hash)
    return {"verdict": result["verdict"], "score": result["score"], "hash": frame_hash}

async def safe_cd_monitoring(frame_dir: Path) -> list[dict]:
    surfaces = [
        (CdContext.CDTE_CSS_ICP_MS,    frame_dir / "icpms_cd_css_result.png"),
        (CdContext.NICD_PASTE_AEROSOL, frame_dir / "aerotrak_cd_paste_mixing.png"),
        (CdContext.URINE_CD_B2MG_BEI,  frame_dir / "icpms_urine_cd_b2mg.png"),
    ]
    tasks = [verify_cd_frame(path, ctx) for ctx, path in surfaces]
    return await asyncio.gather(*tasks)

Glyphward threshold 40 for cadmium monitoring reflects: OSHA 1910.1027 triple-monitoring architecture simultaneously eliminable by coordinated pixel falsification; β₂-microglobulin BEI as sole early-warning marker for irreversible Fanconi nephrotoxicity (biological half-life 15–40 years); ACGIH A1 TLV-TWA of 2 μg/m³ sitting 2.5× below OSHA PEL (OSHA-compliant workplaces still exceed the carcinogen TLV); IARC Group 1 lung cancer and suggestive renal cell carcinoma with 15–40 year latency; and CERCLA RQ 10 lbs for cadmium compounds. First Solar EaglePicher EnerSys Saft VARTA Nyrstar Teck Boliden Antec Toledo Solar.